Global G-CSF and G-CSF Biosimilars Market Insights, Forecast to 2031

Report ID: 1666659 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 G-CSF and G-CSF Biosimilars Product Introduction
    1.2 Market by Type
        1.2.1 Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Blood Disorders
        1.2.3 Oncology Diseases
        1.2.4 Chronic And Autoimmune Diseases
        1.2.5 Growth Hormone Deficiencies
    1.3 Market by Application
        1.3.1 Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Human Growth Hormone
        1.3.3 Erythropoietin
        1.3.4 Monoclonal Antibodies
        1.3.5 Insulin
        1.3.6 Interferon
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global G-CSF and G-CSF Biosimilars Sales Estimates and Forecasts 2017-2028
    2.2 Global G-CSF and G-CSF Biosimilars Revenue Estimates and Forecasts 2017-2028
    2.3 Global G-CSF and G-CSF Biosimilars Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global G-CSF and G-CSF Biosimilars Sales by Region
        2.4.1 Global G-CSF and G-CSF Biosimilars Sales by Region (2017-2022)
        2.4.2 Global Sales G-CSF and G-CSF Biosimilars by Region (2023-2028)
    2.5 Global G-CSF and G-CSF Biosimilars Revenue by Region
        2.5.1 Global G-CSF and G-CSF Biosimilars Revenue by Region (2017-2022)
        2.5.2 Global G-CSF and G-CSF Biosimilars Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global G-CSF and G-CSF Biosimilars Sales by Manufacturers
        3.1.1 Global Top G-CSF and G-CSF Biosimilars Manufacturers by Sales (2017-2022)
        3.1.2 Global G-CSF and G-CSF Biosimilars Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of G-CSF and G-CSF Biosimilars in 2021
    3.2 Global G-CSF and G-CSF Biosimilars Revenue by Manufacturers
        3.2.1 Global G-CSF and G-CSF Biosimilars Revenue by Manufacturers (2017-2022)
        3.2.2 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by G-CSF and G-CSF Biosimilars Revenue in 2021
    3.3 Global G-CSF and G-CSF Biosimilars Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global G-CSF and G-CSF Biosimilars Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global G-CSF and G-CSF Biosimilars Sales by Type
        4.1.1 Global G-CSF and G-CSF Biosimilars Historical Sales by Type (2017-2022)
        4.1.2 Global G-CSF and G-CSF Biosimilars Forecasted Sales by Type (2023-2028)
        4.1.3 Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2028)
    4.2 Global G-CSF and G-CSF Biosimilars Revenue by Type
        4.2.1 Global G-CSF and G-CSF Biosimilars Historical Revenue by Type (2017-2022)
        4.2.2 Global G-CSF and G-CSF Biosimilars Forecasted Revenue by Type (2023-2028)
        4.2.3 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2017-2028)
    4.3 Global G-CSF and G-CSF Biosimilars Price by Type
        4.3.1 Global G-CSF and G-CSF Biosimilars Price by Type (2017-2022)
        4.3.2 Global G-CSF and G-CSF Biosimilars Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global G-CSF and G-CSF Biosimilars Sales by Application
        5.1.1 Global G-CSF and G-CSF Biosimilars Historical Sales by Application (2017-2022)
        5.1.2 Global G-CSF and G-CSF Biosimilars Forecasted Sales by Application (2023-2028)
        5.1.3 Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2028)
    5.2 Global G-CSF and G-CSF Biosimilars Revenue by Application
        5.2.1 Global G-CSF and G-CSF Biosimilars Historical Revenue by Application (2017-2022)
        5.2.2 Global G-CSF and G-CSF Biosimilars Forecasted Revenue by Application (2023-2028)
        5.2.3 Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2017-2028)
    5.3 Global G-CSF and G-CSF Biosimilars Price by Application
        5.3.1 Global G-CSF and G-CSF Biosimilars Price by Application (2017-2022)
        5.3.2 Global G-CSF and G-CSF Biosimilars Price Forecast by Application (2023-2028)
6 North America
    6.1 North America G-CSF and G-CSF Biosimilars Market Size by Type
        6.1.1 North America G-CSF and G-CSF Biosimilars Sales by Type (2017-2028)
        6.1.2 North America G-CSF and G-CSF Biosimilars Revenue by Type (2017-2028)
    6.2 North America G-CSF and G-CSF Biosimilars Market Size by Application
        6.2.1 North America G-CSF and G-CSF Biosimilars Sales by Application (2017-2028)
        6.2.2 North America G-CSF and G-CSF Biosimilars Revenue by Application (2017-2028)
    6.3 North America G-CSF and G-CSF Biosimilars Market Size by Country
        6.3.1 North America G-CSF and G-CSF Biosimilars Sales by Country (2017-2028)
        6.3.2 North America G-CSF and G-CSF Biosimilars Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe G-CSF and G-CSF Biosimilars Market Size by Type
        7.1.1 Europe G-CSF and G-CSF Biosimilars Sales by Type (2017-2028)
        7.1.2 Europe G-CSF and G-CSF Biosimilars Revenue by Type (2017-2028)
    7.2 Europe G-CSF and G-CSF Biosimilars Market Size by Application
        7.2.1 Europe G-CSF and G-CSF Biosimilars Sales by Application (2017-2028)
        7.2.2 Europe G-CSF and G-CSF Biosimilars Revenue by Application (2017-2028)
    7.3 Europe G-CSF and G-CSF Biosimilars Market Size by Country
        7.3.1 Europe G-CSF and G-CSF Biosimilars Sales by Country (2017-2028)
        7.3.2 Europe G-CSF and G-CSF Biosimilars Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific G-CSF and G-CSF Biosimilars Market Size by Type
        8.1.1 Asia Pacific G-CSF and G-CSF Biosimilars Sales by Type (2017-2028)
        8.1.2 Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Type (2017-2028)
    8.2 Asia Pacific G-CSF and G-CSF Biosimilars Market Size by Application
        8.2.1 Asia Pacific G-CSF and G-CSF Biosimilars Sales by Application (2017-2028)
        8.2.2 Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Application (2017-2028)
    8.3 Asia Pacific G-CSF and G-CSF Biosimilars Market Size by Region
        8.3.1 Asia Pacific G-CSF and G-CSF Biosimilars Sales by Region (2017-2028)
        8.3.2 Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America G-CSF and G-CSF Biosimilars Market Size by Type
        9.1.1 Latin America G-CSF and G-CSF Biosimilars Sales by Type (2017-2028)
        9.1.2 Latin America G-CSF and G-CSF Biosimilars Revenue by Type (2017-2028)
    9.2 Latin America G-CSF and G-CSF Biosimilars Market Size by Application
        9.2.1 Latin America G-CSF and G-CSF Biosimilars Sales by Application (2017-2028)
        9.2.2 Latin America G-CSF and G-CSF Biosimilars Revenue by Application (2017-2028)
    9.3 Latin America G-CSF and G-CSF Biosimilars Market Size by Country
        9.3.1 Latin America G-CSF and G-CSF Biosimilars Sales by Country (2017-2028)
        9.3.2 Latin America G-CSF and G-CSF Biosimilars Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa G-CSF and G-CSF Biosimilars Market Size by Type
        10.1.1 Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Type (2017-2028)
        10.1.2 Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Type (2017-2028)
    10.2 Middle East and Africa G-CSF and G-CSF Biosimilars Market Size by Application
        10.2.1 Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Application (2017-2028)
        10.2.2 Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Application (2017-2028)
    10.3 Middle East and Africa G-CSF and G-CSF Biosimilars Market Size by Country
        10.3.1 Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2017-2028)
        10.3.2 Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Pfizer
        11.1.1 Pfizer Corporation Information
        11.1.2 Pfizer Overview
        11.1.3 Pfizer G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Pfizer G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Pfizer Recent Developments
    11.2 Novartis
        11.2.1 Novartis Corporation Information
        11.2.2 Novartis Overview
        11.2.3 Novartis G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Novartis G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Novartis Recent Developments
    11.3 Roche
        11.3.1 Roche Corporation Information
        11.3.2 Roche Overview
        11.3.3 Roche G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Roche G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Roche Recent Developments
    11.4 Merck & Co.
        11.4.1 Merck & Co. Corporation Information
        11.4.2 Merck & Co. Overview
        11.4.3 Merck & Co. G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Merck & Co. G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Merck & Co. Recent Developments
    11.5 Sanofi
        11.5.1 Sanofi Corporation Information
        11.5.2 Sanofi Overview
        11.5.3 Sanofi G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Sanofi G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Sanofi Recent Developments
    11.6 Johnson & Johnson
        11.6.1 Johnson & Johnson Corporation Information
        11.6.2 Johnson & Johnson Overview
        11.6.3 Johnson & Johnson G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Johnson & Johnson G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Johnson & Johnson Recent Developments
    11.7 Gilead Science
        11.7.1 Gilead Science Corporation Information
        11.7.2 Gilead Science Overview
        11.7.3 Gilead Science G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Gilead Science G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Gilead Science Recent Developments
    11.8 GlaxoSmithKline
        11.8.1 GlaxoSmithKline Corporation Information
        11.8.2 GlaxoSmithKline Overview
        11.8.3 GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 GlaxoSmithKline G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 GlaxoSmithKline Recent Developments
    11.9 AbbVie
        11.9.1 AbbVie Corporation Information
        11.9.2 AbbVie Overview
        11.9.3 AbbVie G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 AbbVie G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 AbbVie Recent Developments
    11.10 Amgen
        11.10.1 Amgen Corporation Information
        11.10.2 Amgen Overview
        11.10.3 Amgen G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Amgen G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Amgen Recent Developments
    11.11 AstraZeneca
        11.11.1 AstraZeneca Corporation Information
        11.11.2 AstraZeneca Overview
        11.11.3 AstraZeneca G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 AstraZeneca G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 AstraZeneca Recent Developments
    11.12 Bayer
        11.12.1 Bayer Corporation Information
        11.12.2 Bayer Overview
        11.12.3 Bayer G-CSF and G-CSF Biosimilars Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Bayer G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Bayer Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 G-CSF and G-CSF Biosimilars Industry Chain Analysis
    12.2 G-CSF and G-CSF Biosimilars Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 G-CSF and G-CSF Biosimilars Production Mode & Process
    12.4 G-CSF and G-CSF Biosimilars Sales and Marketing
        12.4.1 G-CSF and G-CSF Biosimilars Sales Channels
        12.4.2 G-CSF and G-CSF Biosimilars Distributors
    12.5 G-CSF and G-CSF Biosimilars Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 G-CSF and G-CSF Biosimilars Industry Trends
    13.2 G-CSF and G-CSF Biosimilars Market Drivers
    13.3 G-CSF and G-CSF Biosimilars Market Challenges
    13.4 G-CSF and G-CSF Biosimilars Market Restraints
14 Key Findings in The Global G-CSF and G-CSF Biosimilars Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer

List of Tables
    Table 1. Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Blood Disorders
    Table 3. Major Manufacturers of Oncology Diseases
    Table 4. Major Manufacturers of Chronic And Autoimmune Diseases
    Table 5. Major Manufacturers of Growth Hormone Deficiencies
    Table 6. Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global G-CSF and G-CSF Biosimilars Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global G-CSF and G-CSF Biosimilars Sales by Region (2017-2022) & (K Units)
    Table 9. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2017-2022)
    Table 10. Global G-CSF and G-CSF Biosimilars Sales by Region (2023-2028) & (K Units)
    Table 11. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2023-2028)
    Table 12. Global G-CSF and G-CSF Biosimilars Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2017-2022)
    Table 14. Global G-CSF and G-CSF Biosimilars Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2023-2028)
    Table 16. Global G-CSF and G-CSF Biosimilars Sales by Manufacturers (2017-2022) & (K Units)
    Table 17. Global G-CSF and G-CSF Biosimilars Sales Share by Manufacturers (2017-2022)
    Table 18. Global G-CSF and G-CSF Biosimilars Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global G-CSF and G-CSF Biosimilars Revenue Share by Manufacturers (2017-2022)
    Table 20. G-CSF and G-CSF Biosimilars Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global G-CSF and G-CSF Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global G-CSF and G-CSF Biosimilars by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in G-CSF and G-CSF Biosimilars as of 2021)
    Table 23. G-CSF and G-CSF Biosimilars Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers G-CSF and G-CSF Biosimilars Product Offered
    Table 25. Date of Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 28. Global G-CSF and G-CSF Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 29. Global G-CSF and G-CSF Biosimilars Sales Share by Type (2017-2022)
    Table 30. Global G-CSF and G-CSF Biosimilars Sales Share by Type (2023-2028)
    Table 31. Global G-CSF and G-CSF Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global G-CSF and G-CSF Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global G-CSF and G-CSF Biosimilars Revenue Share by Type (2017-2022)
    Table 34. Global G-CSF and G-CSF Biosimilars Revenue Share by Type (2023-2028)
    Table 35. G-CSF and G-CSF Biosimilars Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global G-CSF and G-CSF Biosimilars Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 38. Global G-CSF and G-CSF Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 39. Global G-CSF and G-CSF Biosimilars Sales Share by Application (2017-2022)
    Table 40. Global G-CSF and G-CSF Biosimilars Sales Share by Application (2023-2028)
    Table 41. Global G-CSF and G-CSF Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global G-CSF and G-CSF Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global G-CSF and G-CSF Biosimilars Revenue Share by Application (2017-2022)
    Table 44. Global G-CSF and G-CSF Biosimilars Revenue Share by Application (2023-2028)
    Table 45. G-CSF and G-CSF Biosimilars Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global G-CSF and G-CSF Biosimilars Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 48. North America G-CSF and G-CSF Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 49. North America G-CSF and G-CSF Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America G-CSF and G-CSF Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 52. North America G-CSF and G-CSF Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 53. North America G-CSF and G-CSF Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America G-CSF and G-CSF Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America G-CSF and G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 56. North America G-CSF and G-CSF Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 57. North America G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America G-CSF and G-CSF Biosimilars Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 60. Europe G-CSF and G-CSF Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 61. Europe G-CSF and G-CSF Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe G-CSF and G-CSF Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 64. Europe G-CSF and G-CSF Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 65. Europe G-CSF and G-CSF Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe G-CSF and G-CSF Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe G-CSF and G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 68. Europe G-CSF and G-CSF Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 69. Europe G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe G-CSF and G-CSF Biosimilars Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 72. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 73. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 76. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 77. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Region (2017-2022) & (K Units)
    Table 80. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Region (2023-2028) & (K Units)
    Table 81. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 84. Latin America G-CSF and G-CSF Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 85. Latin America G-CSF and G-CSF Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America G-CSF and G-CSF Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 88. Latin America G-CSF and G-CSF Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 89. Latin America G-CSF and G-CSF Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America G-CSF and G-CSF Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America G-CSF and G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 92. Latin America G-CSF and G-CSF Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 93. Latin America G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America G-CSF and G-CSF Biosimilars Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Type (2017-2022) & (K Units)
    Table 96. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Type (2023-2028) & (K Units)
    Table 97. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Application (2017-2022) & (K Units)
    Table 100. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Application (2023-2028) & (K Units)
    Table 101. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2017-2022) & (K Units)
    Table 104. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2023-2028) & (K Units)
    Table 105. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Pfizer Corporation Information
    Table 108. Pfizer Description and Major Businesses
    Table 109. Pfizer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Pfizer G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Pfizer Recent Developments
    Table 112. Novartis Corporation Information
    Table 113. Novartis Description and Major Businesses
    Table 114. Novartis G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Novartis G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Novartis Recent Developments
    Table 117. Roche Corporation Information
    Table 118. Roche Description and Major Businesses
    Table 119. Roche G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Roche G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Roche Recent Developments
    Table 122. Merck & Co. Corporation Information
    Table 123. Merck & Co. Description and Major Businesses
    Table 124. Merck & Co. G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. Merck & Co. G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. Merck & Co. Recent Developments
    Table 127. Sanofi Corporation Information
    Table 128. Sanofi Description and Major Businesses
    Table 129. Sanofi G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Sanofi G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Sanofi Recent Developments
    Table 132. Johnson & Johnson Corporation Information
    Table 133. Johnson & Johnson Description and Major Businesses
    Table 134. Johnson & Johnson G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 135. Johnson & Johnson G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Johnson & Johnson Recent Developments
    Table 137. Gilead Science Corporation Information
    Table 138. Gilead Science Description and Major Businesses
    Table 139. Gilead Science G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 140. Gilead Science G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Gilead Science Recent Developments
    Table 142. GlaxoSmithKline Corporation Information
    Table 143. GlaxoSmithKline Description and Major Businesses
    Table 144. GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 145. GlaxoSmithKline G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. GlaxoSmithKline Recent Developments
    Table 147. AbbVie Corporation Information
    Table 148. AbbVie Description and Major Businesses
    Table 149. AbbVie G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 150. AbbVie G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. AbbVie Recent Developments
    Table 152. Amgen Corporation Information
    Table 153. Amgen Description and Major Businesses
    Table 154. Amgen G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 155. Amgen G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Amgen Recent Developments
    Table 157. AstraZeneca Corporation Information
    Table 158. AstraZeneca Description and Major Businesses
    Table 159. AstraZeneca G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 160. AstraZeneca G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. AstraZeneca Recent Developments
    Table 162. Bayer Corporation Information
    Table 163. Bayer Description and Major Businesses
    Table 164. Bayer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 165. Bayer G-CSF and G-CSF Biosimilars Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Bayer Recent Developments
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. G-CSF and G-CSF Biosimilars Distributors List
    Table 170. G-CSF and G-CSF Biosimilars Customers List
    Table 171. G-CSF and G-CSF Biosimilars Market Trends
    Table 172. G-CSF and G-CSF Biosimilars Market Drivers
    Table 173. G-CSF and G-CSF Biosimilars Market Challenges
    Table 174. G-CSF and G-CSF Biosimilars Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. G-CSF and G-CSF Biosimilars Product Picture
    Figure 3. Global G-CSF and G-CSF Biosimilars Market Share by Type in 2021 & 2028
    Figure 3. Blood Disorders Product Picture
    Figure 4. Oncology Diseases Product Picture
    Figure 5. Chronic And Autoimmune Diseases Product Picture
    Figure 6. Growth Hormone Deficiencies Product Picture
    Figure 7. Global G-CSF and G-CSF Biosimilars Market Share by Application in 2021 & 2028
    Figure 8. Human Growth Hormone
    Figure 9. Erythropoietin
    Figure 10. Monoclonal Antibodies
    Figure 11. Insulin
    Figure 12. Interferon
    Figure 13. G-CSF and G-CSF Biosimilars Report Years Considered
    Figure 14. Global G-CSF and G-CSF Biosimilars Sales 2017-2028 (K Units)
    Figure 15. Global G-CSF and G-CSF Biosimilars Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 16. Global G-CSF and G-CSF Biosimilars Revenue 2017-2028 (US$ Million)
    Figure 17. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 18. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2017-2022)
    Figure 19. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2023-2028)
    Figure 20. North America G-CSF and G-CSF Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 21. North America G-CSF and G-CSF Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Europe G-CSF and G-CSF Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 23. Europe G-CSF and G-CSF Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Asia-Pacific G-CSF and G-CSF Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 25. Asia-Pacific G-CSF and G-CSF Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Latin America G-CSF and G-CSF Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 27. Latin America G-CSF and G-CSF Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. Middle East & Africa G-CSF and G-CSF Biosimilars Sales YoY (2017-2028) & (K Units)
    Figure 29. Middle East & Africa G-CSF and G-CSF Biosimilars Revenue YoY (2017-2028) & (US$ Million)
    Figure 30. The G-CSF and G-CSF Biosimilars Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 31. The Top 5 and 10 Largest Manufacturers of G-CSF and G-CSF Biosimilars in the World: Market Share by G-CSF and G-CSF Biosimilars Revenue in 2021
    Figure 32. Global G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 33. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2028)
    Figure 34. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 35. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2028)
    Figure 36. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 37. North America G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2028)
    Figure 38. North America G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 39. North America G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2028)
    Figure 40. North America G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 41. North America G-CSF and G-CSF Biosimilars Sales Share by Country (2017-2028)
    Figure 42. North America G-CSF and G-CSF Biosimilars Revenue Share by Country (2017-2028)
    Figure 43. U.S. G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 44. Canada G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 45. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2028)
    Figure 46. Europe G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 47. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2028)
    Figure 48. Europe G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 49. Europe G-CSF and G-CSF Biosimilars Sales Share by Country (2017-2028)
    Figure 50. Europe G-CSF and G-CSF Biosimilars Revenue Share by Country (2017-2028)
    Figure 51. Germany G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 52. France G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 53. U.K. G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 54. Italy G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 55. Russia G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 56. Asia Pacific G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2028)
    Figure 57. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 58. Asia Pacific G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2028)
    Figure 59. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 60. Asia Pacific G-CSF and G-CSF Biosimilars Sales Share by Region (2017-2028)
    Figure 61. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Share by Region (2017-2028)
    Figure 62. China G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 63. Japan G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 64. South Korea G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 65. India G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 66. Australia G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 67. Taiwan G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 68. Indonesia G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 69. Thailand G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 70. Malaysia G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 71. Philippines G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 72. Latin America G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2028)
    Figure 73. Latin America G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 74. Latin America G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2028)
    Figure 75. Latin America G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 76. Latin America G-CSF and G-CSF Biosimilars Sales Share by Country (2017-2028)
    Figure 77. Latin America G-CSF and G-CSF Biosimilars Revenue Share by Country (2017-2028)
    Figure 78. Mexico G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 79. Brazil G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 80. Argentina G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 81. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share by Type (2017-2028)
    Figure 82. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share by Application (2017-2028)
    Figure 84. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Share by Country (2017-2028)
    Figure 86. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Share by Country (2017-2028)
    Figure 87. Turkey G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 88. Saudi Arabia G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 89. U.A.E G-CSF and G-CSF Biosimilars Revenue (2017-2028) & (US$ Million)
    Figure 90. G-CSF and G-CSF Biosimilars Value Chain
    Figure 91. G-CSF and G-CSF Biosimilars Production Process
    Figure 92. Channels of Distribution
    Figure 93. Distributors Profiles
    Figure 94. Bottom-up and Top-down Approaches for This Report
    Figure 95. Data Triangulation
    Figure 96. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
Frequently Asked Questions
G-CSF and G-CSF Biosimilars report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
G-CSF and G-CSF Biosimilars report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
G-CSF and G-CSF Biosimilars report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Steel Silo

Steel Silo market is segmented by Type and by Application. Players, stakeholders, and other parti ... Read More